Role of Sema4C in TGF-β1-induced mitogen-activated protein kinase activation and epithelialmesenchymal transition in renal tubular epithelial cells

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1149-1156

  Zeng, Rui ^a   Han, Min ^a   Luo, Yun ^a   Li, Caixia ^a   Pei, Guangchang ^a   Liao, Wenhui ^b   Bai, Shoujun ^a   Ge, Shuwang ^a   Liu, Xiaocheng ^a   Xu, Gang ^a  

^a Tongji Hospital   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

epithelial to mesenchymal transition; p38 MAPK; Sema4C; TGF 1

Indexed keywords

FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN SEMA4C; SEMAPHORIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY TUBULE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TARGETING; RAT; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY TUBULES, PROXIMAL; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEPHRECTOMY; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SEMAPHORINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79953878862     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq619     Document Type: Article

References (32)

1. Maria P, Rastaldi FF, Giardino L et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002; 62: 137-146 (Pubitemid 34754056)
2. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1-12 (Pubitemid 38020692)
3. MP R. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis. J Nephrol 2006; 19: 407-412
4. Surmeet Bedi AV, Arjang D. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando) 2008; 22: 1-5
5. Lan HY. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 2003; 12: 25-29 (Pubitemid 36092311)
6. Ahmad H, Bani-Hania MTC, Daniel R et al. Cytokines in epithelial- mesenchymal transition: a new insight into obstructive nephropathy. J Urol 2008; 180: 461-468
7. Moustakas AHC. Non-Smad TGF-beta signals. J Cell Sci 2005; 118: 3573-3584
8. Zhang YE. Non-Smad pathways in TGF-signaling. Cell Res 2009; 19: 128-139
9. Dong Young Rhyu YY, Hunjoo H et al. Role of reactive oxygen species in TGF-1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 2005; 16: 667-675
10. Attila Sebe S-KL, Attila Fet al. Transforming growth factor-β- induced alpha-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38β mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the Smad signaling during epithelial-myofibroblast transdifferentiation. Nephrol Dial Transplant 2008; 23: 1537-1545
11. Wu H, Wang X, Liu S et al. Sema4C participates in myogenic differentiation in vivo and in vitro through the p38 MAPK pathway. Eur J Cell Biol 2007; 86: 331-344 (Pubitemid 46825256)
12. Kruger RP, Aurandt J, Guan K-L. Semaphorins command cells to move. Nat Rev Mol Cell Biol 2005; 6: 789-800 (Pubitemid 41726117)
13. Basile JR, Barac A, Zhu T et al. Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 2004; 64: 5212-5224 (Pubitemid 39006540)
14. Pasterkamp RJ, Peschon JJ, Spriggs MK et al. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 2003; 424: 398-405 (Pubitemid 36917482)
15. Suzuki K, Kumanogoh A, Kikutani H. Semaphorins and their receptors in immune cell interactions. Nat Immunol 2008; 9: 17-23 (Pubitemid 350286199)
16. JP TJS. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142
17. Hou CC, Wang W, Huang XR et al. Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-β signaling and fibrosis in rat remnant kidney. Am J Pathol 2005; 166: 761-771 (Pubitemid 40315633)
18. Böttinger EP. TGF-beta in renal injury and disease. Semin Nephrol 2007; 27: 309-320
19. Yigong Shi JM. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003; 113: 685-700
20. Ulrich Valcourt MK, Hideki N, Carl-Henrik H et al. TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 2005; 16: 1987-2002
21. Galliher AJ, Schiemann WP. Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 2007; 67: 3752-3758 (Pubitemid 46762161)
22. Galliher-Beckley AJ, Schiemann WP. Grb2 binding to Tyr284 in TβR-II is essential for mammary tumor growth and metastasis stimulated by TGF-β. Carcinogenesis 2008; 29: 244-251 (Pubitemid 351359662)
23. Bakin AV, Rinehart C, Tomlinson AK et al. p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdiffer-entiation and cell migration. J Cell Sci 2002; 115: 3193-3206
24. Lewitzky M, Kardinal C, Gehring NH et al. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif. Oncogene 2001; 20: 1052-1062 (Pubitemid 32238854)
25. Shaldon S, Vienken J. The long forgotten salt factor and the benefits of using a 5-g-salt-restricted diet in all ESRD patients. Nephrol Dial Transplant 2008; 23: 2118-2120 (Pubitemid 351957633)
26. Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 1998; 32: 720-724 (Pubitemid 28516300)
27. Daugirdas JT, Al-Kudsi RR, Ing TS et al. A double-blind evaluation of sodium gradient hemodialysis. Am J Nephrol 1985; 5: 163-168 (Pubitemid 15120349)
28. Basile C, Giordano R, Vernaglione L et al. Efficacy and safety of haemodialysis treatment with the hemocontrol biofeedback system: a prospective medium-term study. Nephrol Dial Transplant 2001; 16: 328-334 (Pubitemid 32123922)
29. Giovannetti S, Barsotti G, Cupisti A et al. Dipsogenic factors operating in chronic uremics on maintenance hemodialysis. Nephron 1994; 66: 413-420 (Pubitemid 24083585)
30. Peixoto AJ, Gowda N, Parikh CR et al. Long-term stability of serum sodium in hemodialysis patients. Blood Purif 2010; 29: 264-267
31. Lindley EJ. Reducing sodium intake in hemodialysis patients. Semin Dial 2009; 22: 260-263
32. Agarwal R, Peixoto AJ, Santos SF et al. Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 2006; 1: 389-398